Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
5
×
biotech
boston blog main
boston top stories
cancer
5
×
life sciences
national
national blog main
national top stories
pfizer
5
×
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
astrazeneca
drugs
eli lilly
johnson & johnson
medical device
novartis
startups
alzheimer's disease
amgen
What
bio
drug
roundup
annual
blood
conference
week
acquisitions
alzheimer’s
american
approved
ash
assessed
attention
biggest
biotech
borne
broader
build
buy
cancer
cancers
ceo
communities
companies
company
company’s
daniel
debut
detect
developing
diego
digital
disease
dyne’s
epidemic
esmo
europe
fatty
fda
Language
unset
Current search:
pfizer
×
abbvie
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More